Skip to content

Latest Analysis

The latest in federal health policy.

RECENT UPDATES

Ways and Means Committee Examines H.R. 3, the Lower Drug Costs Now Act, and Education and Labor Committee Favorably Reports AINS to H.R. 3

The House Ways and Means Committee convened a hearing to discuss H.R. 3, the Lower Drug Costs Now Act (summary). The Ways and Means Committee is the third House Committee to examine the bill. Witnesses testified about the difficulties both privately insured beneficiaries and Medicare beneficiaries face in affording their medications and how H.R. 3 savings could be reinvested into… (Slifer, 10/17/19) #Insurance Reform, #Medicare Part D, #Prescription Drugs

Subcommittee Examines E-Cigarettes and Youth Tobacco Epidemic

The House Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies convened a hearing to examine the Centers for Disease Control and Prevention’s (CDC) ongoing investigation of lung injury associated with e-cigarette use, discuss the youth tobacco epidemic, and identify public policy remedies. Overall, members from both parties agreed that efforts should be made to prevent children… (Llamas, 10/16/19) #Food and Drug Administration, #Pediatrics, #Public Health

Initial Cost Estimates of H.R. 3; Price Negotiation, Inflation Rebates Analyzed

The Congressional Budget Office (CBO) released a preliminary cost estimate of title I of the Lower Drug Costs Now Act of 2019 (H.R. 3) regarding price negotiation of certain prescription drugs in Medicare Part D. CBO estimates that enacting title I would reduce federal spending for Medicare by $345 billion over the 2023-2029 period. A summary follows below. Title I… (Llamas) #Insurance Reform, #Medicare Part D, #Prescription Drugs

Report on State Of Childhood Obesity Offers Policy Recommendations to Improve Obesity Disparities

The Robert Wood Johnson Foundations (RWJF) published a report on the state of childhood obesity detailing that fifteen percent of American children ages 10 to 17 are obese and disparities exist along socioeconomic, racial, and ethnic lines. The report found that almost 22 percent of children in homes making less than the federal poverty level (FPL) were obese, compared to… (Slifer, 10/10/19) #Pediatrics, #Social Determinants of Health, #Nutrition

Agency, along with OIG, Proposes Reforms to Stark Law, Anti-Kickback to Promote Value-Based Care

The Department of Health and Human Services (HHS) announced highly-anticipated proposed reforms to the Physician Self-Referral Law (the “Stark Law”) and the Federal Anti-Kickback Statute (AKS), including relevant civil monetary penalty (CMP) provisions, the latter of which prohibit inducements to beneficiaries (“beneficiary inducements CMP”). HHS identified these laws as collective potential impediments to the proliferation of value-based and coordinated care… (Pahner & LaRosa, 10/9/19) #Value-Based Purchasing, #Care Coordination, #Self-Referral

Agency Begins Review of FDA Drug Importation Guidance

The Office of Management and Budget (OMB) has received for review Food and Drug Administration (FDA) guidance on the importation of certain FDA-approved prescription drugs and biological products. The guidance will be released in draft form, allowing stakeholders and opportunity to submit comments before its ultimate finalization. The arrival of this guidance marks the first tangible development following the administration’s… (LaRosa, 10/8/19) #Food and Drug Administration, #Drug Pricing

Become a PolicyHub member for full access to our latest analysis. Learn about all the health issues we cover, from A to Z.

CONTACT US

Improving Health is Our Policy